Table 3 Univariate and multivariate logistic regression of factors associated with progression of GH towards PE among pregnant women in ACSH and MGH, 2016/ 2017 (N = 240)
Variables | Maternal outcome | OR (95 % CI) | ||
|---|---|---|---|---|
GH-GH N = 199 | GH-PE N = 41 | COR (95 %CI) | AOR (95 %CI) | |
Maternal age (year) | ||||
< 35 | 168(84.4 %) | 31 (75.6 %) | 1 | |
≥ 35 | 31(15.6 %) | 10 (24.4 %) | 1.74 (0.79–3.9) | |
Gestational age at diagnosis (week) | ||||
< 34 | 56 (28.1 %) | 12 (29.3 %) | 2.47 ( 0.76–5.35) | |
≥ 34 | 143 (71.9 %) | 29 (70.7 %) | 1 | |
Gravidity | ||||
1 | 81(40.7 %) | 16 (39 %) | 3.68 (0.89–4.56) | 3.2 (1.32–5.64) |
> 1 | 118(59.3 %) | 25 (61 %) | 1 | 1 |
Abortion | ||||
Yes | 173 (86.9 %) | 19(46.3 %) | 7.69(5.0-9.09)* | 3.84(1.07-25.0)* |
No | 26 (13.1 %) | 22(53.7 %) | 1 | 1 |
Previous history of GH | ||||
Yes | 3 (1.5 %) | 19 (46.3 %) | 28.43 (2.92–49.12)* | 26.76 (3.03–49.08)* |
No | 196 (98.5 %) | 22 (53.7 %) | 1 | 1 |
Family history of chronic hypertension | ||||
Yes | 17 (8.5 %) | 3 (7.3 %) | 2.13 (0.73–4.32) | |
No | 182 (91.5 %) | 38 (92.7 %) | 1 | |
Hemoglobin (g/dl) | ||||
7-<11 | 13 (6.5 %) | 22 (53.7 %) | 13.71(3.96–22.40)* | 13.1(1.40-17.27)* |
>=11 | 186 (9.2 %) | 19 (46.3 %) | 1 | 1 |